Rabeprazole 20 Tablet

Rabeprazole 20 Tablet সম্পর্কে

বাংলাদেশে Rabeprazole 20 Tablet ট্যাবলেট হিসেবে পাওয়া যায়; এতে Rabeprazole Sodium আছে (২০ mg)। এই ব্র্যান্ডের প্রস্তুতকারক Indo-Bangla Pharmaceuticals Ltd। Rabeprazole 20-এর সাথে Rabeprazole Sodium-এর অন্য ব্র্যান্ডের দাম নিচে তুলনা করে দেখুন। ডাক্তারের প্রেসক্রিপশন মেনে চলুন এবং অন্য ব্র্যান্ড খাওয়া যাবে কি না তা ফার্মাসিস্টের কাছ থেকে জেনে নিন।

Rabeprazole Sodium-এর ৪৮টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। সবচেয়ে কম দাম Acifix 10 mg Sprinkle Capsule-এর, প্রতি ইউনিট ৳ ৩.৫০।

Rabeprazole 20 Tablet কী?

Rabeprazole 20 20 mg tablet is a medicine made by Indo-Bangla Pharmaceuticals Ltd. Rabeprazole 20 20 mg tablet belongs to a group of medicines called proton pump inhibitors. Always follow the doctor's instructions for use.

Rabeprazole 20-এর ব্যবহার

It is also used for symptomatic erosive or ulcerative gastro-oesophageal reflux disease (GERD). It may additionally be used for symptom relief in moderate to very severe GERD. Your doctor will confirm whether it is suitable for your condition.

Rabeprazole 20 কীভাবে ব্যবহার করবেন

Swallow the enteric-coated tablet as your doctor advises; the doctor decides the dose and how long the course lasts. Swallow the tablet with water. Rabeprazole 20 is taken by mouth. Take Rabeprazole 20 exactly as your doctor prescribes. The doctor decides the dose and how long the course should last, so follow their instructions and do not change the schedule yourself. Do not change the dose or stop early on your own.

Rabeprazole 20-এর পার্শ্বপ্রতিক্রিয়া

Ask them about anything you notice while taking it. Common ones include headache, diarrhoea, abdominal pain, vomiting, constipation, dry mouth, changes in appetite, muscle pain, drowsiness, and dizziness. Most people tolerate the medicine well, but if you experience any side effects, contact your doctor. Do not stop the medicine on your own without medical advice.

সতর্কতা ও নিরাপত্তা

A response to treatment does not rule out stomach or oesophageal cancer, so the doctor should exclude this before treatment begins. Long-term use may require regular check-ups. The doctor may need to exclude serious conditions before starting treatment. Ask your doctor if you have any concerns about taking this medicine.

সাধারণ প্রশ্ন

What does Rabeprazole 20 treat?

It is also used for symptomatic erosive or ulcerative gastro-oesophageal reflux disease (GERD). It may additionally be used for symptom relief in moderate to very severe GERD.

How should I take Rabeprazole 20?

Swallow the enteric-coated tablet as your doctor advises; the doctor decides the dose and how long the course lasts. Swallow the tablet with water.

Can Rabeprazole 20 cause side effects?

Ask them about anything you notice while taking it. Common ones include headache, diarrhoea, abdominal pain, vomiting, constipation, dry mouth, changes in appetite, muscle pain, drowsiness, and dizziness.

Is Rabeprazole 20 safe for everyone?

A response to treatment does not rule out stomach or oesophageal cancer, so the doctor should exclude this before treatment begins. Long-term use may require regular check-ups.

নির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Rabeprazole Gastro-resistant tablets are indicated for the treatment of:
  • Active duodenal ulcer
  • Active benign gastric ulcer
  • Symptomatic erosive or ulcerative gastro-esophageal reflux disease (GERD).
  • Gastro-esophageal Reflux Disease Long-term Management (GERD Maintenance)
  • ... Read more
Rabeprazole Gastro-resistant tablets are indicated for the treatment of:
  • Active duodenal ulcer
  • Active benign gastric ulcer
  • Symptomatic erosive or ulcerative gastro-esophageal reflux disease (GERD).
  • Gastro-esophageal Reflux Disease Long-term Management (GERD Maintenance)
  • Symptomatic treatment of moderate to very severe gastro-esophageal reflux disease (symptomatic GERD)
  • Zollinger-Ellison Syndrome
  • In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori in patients with peptic ulcer disease.

ফার্মাকোলজি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Rabeprazole suppresses gastric acid secretion by inhibiting the gastric H+/K+-ATPase at the secretory surface of the gastric parietal cell. Because this enzyme is regarded as the acid (proton) pump within the parietal cell, Rabeprazole has been characterized as a gastric proton-pump inhibitor.

মাত্রা ও সেবনবিধি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Active Duodenal Ulcer and Active Benign Gastric Ulcer: The recommended oral dose for both bioactive duodenal ulcer and active benign gastric ulcer is 20 mg to be taken once daily in the morning. Most patients with active duodenal ulcer heal within four weeks. However, a few patients may require an additional four weeks of therapy to achieve healing. Most patients with active benign gastric ulcer heal within six weeks. However, again a few patients may require an additional six weeks of therapy to achieve healing.

Erosive or Ulcerative Gastro-Esophageal Reflux Disease (GERD): The recommended oral dose for this condition is 20 mg to be taken once daily for four to eight weeks.

Gastro-Esophageal Reflux Disease Long-term Management (GERD Maintenance): For long-term management, a maintenance dose of rabeprazole sodium 20 mg or 10 mg once daily can be used depending upon patient response.

Symptomatic treatment of moderate to very severe Gastro-Esophageal Reflux Disease (symptomatic GERD): 10 mg once daily in patients without oesophagitis. If symptom control has not been achieved during four weeks, the patient should be further investigated. Once symptoms have resolved, subsequent symptom control can be achieved using an on-demand regimen taking 10 mg once daily when needed.

Treatment of GERD in pediatric patients 1 to 11 years of age (Less than 15 kg): 5 mg once daily for 12 weeks with the option to increase to 10 mg if inadequate response.

Treatment of GERD in pediatric patients 1 to 11 years of age (15 kg or more): 10 mg once daily for 12 weeks. 

Zollinger-Ellison Syndrome: The recommended adult starting dose is 60 mg once a day. The dose may be titrated upwards to 120 mg/day based on individual patient needs. Single daily doses up to 100 mg/day may be given. 120 mg dose may require divided doses, 60 mg twice daily. Treatment should continue for as long as clinically indicated.

Eradication of H. pylori: Patients with H. pylori infection should be treated with eradication therapy. The following combination given for 7 days is recommended. Rabeprazole sodium 20 mg twice daily, clarithromycin 500 mg twice daily and amoxicillin 1g twice daily.

ঔষধের মিথষ্ক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Respite produces a profound and long-lasting inhibition of gastric acid secretion. An interaction with a compound whose absorption is pH dependent may occur. Co-administration of rabeprazole sodium with ketoconazole or itraconazole may result in a significant decrease in antifungal plasma levels. Therefore individual patients may need to be monitored to determine if a dosage adjustment is necessary when ketoconazole or itraconazole are taken concomitantly with Respite. No interaction with liquid antacids was observed. The absorption of atazanavir is pH-dependent. Therefore PPIs, including rabeprazole, should not be co-administered with atazanavir.

প্রতিনির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Hypersensitivity to the active substance or to any of the excipients. Rabeprazole is contra-indicated in pregnancy and during breastfeeding.

পার্শ্ব প্রতিক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

In general, Rabeprazole is well-tolerated in both short-term and long-term studies. Rabeprazole may sometimes cause headache, diarrhoea, abdominal pain, vomiting, constipation, dry mouth, increased or decreased appetite, muscle pain, drowsiness, dizziness.

গর্ভাবস্থায় ও স্তন্যদানকালে

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

US FDA pregnancy category 'C'. Studies have been performed in animals and have revealed no evidence of impaired fertility or harm to the fetus due to Rabeprazole. There are however, no adequate and well-controlled studies in pregnant women. Rabeprazole is likely to be excreted in human milk, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

সতর্কতা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

  • Symptomatic response to therapy with Rabeprazole does not preclude the presence of gastric or oesophageal malignancy, therefore the possibility of malignancy should be excluded prior to commencing treatment with Rabeprazole 20 mg Gastro-resistant Tablets.
  • Patients on long-term treatment (particularly those treated for more than a year) should be kept under regular surveillance.
  • Proton pump inhibitors, especially if used in high doses and over long durations (>1 year), may modestly increase the risk of hip, wrist and spine fracture, predominantly in the elderly or in presence of other recognised risk factors. Observational studies suggest that proton pump inhibitors may increase the overall risk of fracture by 10–40%. Some of this increase may be due to other risk factors. Patients at risk of osteoporosis should receive care and they should have an adequate intake of vitamin D and calcium.
  • A risk of cross-hypersensitivity reactions with other proton pump inhibitor or substituted benzimidazoles cannot be excluded.
  • Patients should be cautioned that Rabeprazole gastro-resistant tablets should not be chewed or crushed, but should be swallowed whole.
  • There have been post marketing reports of blood dyscrasias (thrombocytopenia and neutropenia). In the majority of cases where an alternative aetiology cannot be identified, the events were uncomplicated and resolved on discontinuation of rabeprazole.
  • Hepatic enzyme abnormalities have been seen in clinical trials and have also been reported since market authorisation. In the majority of cases where an alternative aetiology cannot be identified, the events were uncomplicated and resolved on discontinuation of rabeprazole.
  • No evidence of significant drug related safety problems was seen in a study of patients with mild to moderate hepatic impairment versus normal age and sex matched controls. However because there are no clinical data on the use of rabeprazole in the treatment of patients with severe hepatic dysfunction the prescriber is advised to exercise caution when treatment with Rabeprazole 20mg Gastro-resistant. Tablets is first initiated in such patients.
  • Co-administration of atazanavir with Rabeprazole is not recommended.
  • Treatment with proton pump inhibitors, including rabeprazole, may possibly increase the risk of gastrointestinal infections such as Salmonella, Campylobacter and Clostridium difficile.
Hypomagnesaemia: Severe hypomagnesaemia has been reported in patients treated with PPIs like rabeprazole for at least three months, and in most cases for a year. Serious manifestations of hypomagnesaemia such as fatigue, tetany, delirium, convulsions, dizziness and ventricular arrhythmia can occur but they may begin insidiously and be overlooked. In most affected patients, hypomagnesaemia improved after magnesium replacement and discontinuation of the PPI. For patients expected to be on prolonged treatment or who take PPIs with digoxin or drugs that may cause hypomagnesaemia (e.g., diuretics), health care professionals should consider measuring magnesium levels before starting PPI treatment and periodically during treatment.

Influence on vitamin B12 absorption: Rabeprazole sodium, as all acid-blocking medicines, may reduce the absorption of vitamin B12 (cyanocobalamin) due to hypo- or a- chlorhydria. This should be considered in patients with reduced body stores or risk factors for reduced vitamin B12 absorption on long-term therapy or if respective clinical symptoms are observed.

Subacute cutaneous lupus erythematosus (SCLE): Proton pump inhibitors are associated with very infrequent cases of SCLE. If lesions occur, especially in sun-exposed areas of the skin, and if accompanied by arthralgia, the patient should seek medical help promptly and the health care professional should consider stopping Rabeprazole. SCLE after previous treatment with a proton pump inhibitor may increase the risk of SCLE with other proton pump inhibitors.

Interference with laboratory tests: Increased Chromogranin A (CgA) level may interfere with investigations for neuroendocrine tumours. To avoid this interference, Rabeprazole 20mg Gastro-resistant Tablets treatment should be stopped for at least 5 days before CgA measurements. If CgA and gastrin levels have not returned to reference range after initial measurement, measurements should be repeated 14 days after cessation of proton pump inhibitor treatment.

মাত্রাধিক্যতা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

The maximum established exposure has not exceeded 60 mg twice daily, or 160 mg once daily. Effects are  generally minimal, representative of the known adverse event profile and reversible without further medical intervention. No specific antidote is known. Rabeprazole is extensively protein bound and is, therefore, not dialysable. As in any case of overdose, treatment should be symptomatic and general supportive measures should be utilised.

সংরক্ষণ

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.

বিকল্প ব্র্যান্ড: Rabeprazole Sodium

একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।

Acifix Sprinkle Capsule

10 mg

Rabeprazole Sodium

Beximco Pharmaceuticals PLC.

৳ ৩.৪৩ ৳ ৩.৫০ ২% ছাড় প্রতি ইউনিট

Finix Capsule

10 mg

Rabeprazole Sodium

Opsonin Pharma Limited

৳ ৩.৪৩ ৳ ৩.৫ ২% ছাড় প্রতি ইউনিট

Profast Tablet

20 mg

Rabeprazole Sodium

Renata PLC.

৳ ৪.৯ ৳ ৫.০০ ২% ছাড় প্রতি ইউনিট

Rabecare Tablet

10 mg

Rabeprazole Sodium

Novelta Bestway Pharmaceuticals Ltd.

৳ ৪.৯২ ৳ ৫.০২ ২% ছাড় প্রতি ইউনিট

Rabeprol Tablet

20 mg

Rabeprazole Sodium

Somatec Pharmaceuticals Ltd.

৳ ৫.৬৪ ৳ ৫.৭৫ ২% ছাড় প্রতি ইউনিট

R-20 Tablet

20 mg

Rabeprazole Sodium

Asiatic Laboratories Ltd.

৳ ৫.৮৮ ৳ ৬.০০ ২% ছাড় প্রতি ইউনিট

Rabecon Tablet

20 mg

Rabeprazole Sodium

Biopharma Ltd.

৳ ৫.৮৮ ৳ ৬.০০ ২% ছাড় প্রতি ইউনিট

RP-20 Tablet

20 mg

Rabeprazole Sodium

Globe Pharmaceuticals Ltd.

৳ ৬.৭৬ ৳ ৬.৯ ২% ছাড় প্রতি ইউনিট

Acifix Tablet (Enteric Coated)

20 mg

Rabeprazole Sodium

Beximco Pharmaceuticals PLC.

৳ ৬.৮৬ ৳ ৭.০০ ২% ছাড় প্রতি ইউনিট

Acipra Capsule (Enteric Coated)

20 mg

Rabeprazole Sodium

Alco Pharma Ltd.

৳ ৬.৮৬ ৳ ৭.০০ ২% ছাড় প্রতি ইউনিট

সব দেখুন ৪৮ ব্র্যান্ড

ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।